NUVB (STOCKS)
Nuvation Bio Inc.
$6.078100
-0.341900 (-5.33%)
Prev close: $6.420000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David T. Hung
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,244.12M
- Employees
- 291
- P/E (TTM)
- -14.02
- P/B (TTM)
- 8.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $169.90M |
| Benefits Costs and Expenses | $319.73M |
| Costs And Expenses | $319.73M |
| Nonoperating Income/Loss | -$12.20M |
| Operating Expenses | $312.20M |
| Selling, General, and Administrative Expenses | $158.59M |
| Depreciation and Amortization | $2.15M |
| Research and Development | $128.85M |
| Other Operating Expenses | $17.95M |
| Operating Income/Loss | -$137.63M |
| Income/Loss From Continuing Operations After Tax | -$149.83M |
| Income/Loss From Continuing Operations Before Tax | -$149.83M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$149.83M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$149.83M |
| Net Income/Loss Available To Common Stockholders, Basic | -$149.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.44 |
| Diluted Earnings Per Share | -$0.44 |
| Basic Average Shares | 691,392 |
| Diluted Average Shares | 691,392 |
| Assets | $744.50M |
| Current Assets | $726.43M |
| Inventory | $19.90M |
| Other Current Assets | $706.53M |
| Noncurrent Assets | $18.07M |
| Fixed Assets | $715.00K |
| Other Non-current Assets | $17.36M |
| Liabilities | $490.64M |
| Current Liabilities | $86.76M |
| Accounts Payable | $12.09M |
| Other Current Liabilities | $74.67M |
| Noncurrent Liabilities | $403.88M |
| Long-term Debt | $242.62M |
| Other Non-current Liabilities | $161.26M |
| Equity | $253.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $253.86M |
| Liabilities And Equity | $744.50M |
| Net Cash Flow From Operating Activities | -$120.52M |
| Net Cash Flow From Operating Activities, Continuing | -$120.52M |
| Net Cash Flow From Investing Activities | -$47.18M |
| Net Cash Flow From Investing Activities, Continuing | -$47.18M |
| Net Cash Flow From Financing Activities | $179.14M |
| Net Cash Flow From Financing Activities, Continuing | $179.14M |
| Exchange Gains/Losses | -$798.00K |
| Net Cash Flow | $10.63M |
| Net Cash Flow, Continuing | $11.43M |
| Comprehensive Income/Loss | -$152.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$152.11M |
| Other Comprehensive Income/Loss | $110.12M |